Qiagen NV | QIA - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
argenx SE USD 426M 22.71M 2026-03
Avita Medical AUD -11.64M 12.13M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Ionis Pharmaceuticals USD -114M 21M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Moderna USD -1.33B 535M 2026-03
Organon & Co USD 183M 30M 2026-06
Qiagen NV USD 157.9M 72.08M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Tectonic Therapeutic USD -18.97M 63K 2025-12
Viatris USD -247.3M 95.7M 2026-03
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03